Propensity score matching and covariates Patients in the GLP-1 agonists group were matched to a patient in the non-GLP-1 agonists group using 1:1 propensity score matching (PSM) to reduce confounders 22
(Source) Intestinal obstructions: One study found that participants who took an incretin-based drug (e.g, a GLP-1 like Ozempic) were over 4.5 times more likely to report having an intestinal obstruction than those taking other diabetes medications
and in my state
[DOI] [PubMed] [Google Scholar] 43.Jayashri R., Venkatesan U., Rohan M., Gokulakrishnan K., Shanthi Rani C.S., Deepa M., Anjana R.M., Mohan V., Pradeepa R
We recommend a 3-month course for exceptional effects
Start your intake Timeline: When Tirzepatide Appetite Suppression Begins Tirzepatide enters your bloodstream and reaches peak concentration within 872 hours, depending on whether you're using the injectable or oral form